Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ivologist vs Queen RX

Ivologist
Graded #215

Lower grade

vs+0.20000000000000284
Queen RX
Graded #212

Higher grade

The verdict

Queen RX takes it — 66/100 to 65.8/100, but only just.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo). Ivologist is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +6
70
76
Dose & formulationQueen RX +5
52
57
Clinical oversightIvologist +15
84
69
Labs & monitoringEven
53
53
FulfillmentIvologist +10
85
75
Contract termsQueen RX +24
37
61
Ivologist · left barQueen RX · right bar

The numbers

MetricIvologistQueen RX
WeighScore65.8/10066/100
GradeCC
Scorecard rank#215#212
Semaglutide$145/mo (compounded)$100/mo (quarterly plan, compounded)
TirzepatideNot disclosedNot disclosed
CoverageAll 50 states45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Ivologist

Graded #215 · C

Strengths

  • LegitScript certified
  • All 50 states coverage
  • No monthly contracts, memberships, or autodrafts
  • Over 20,000 patients served
  • Both semaglutide and tirzepatide available

Where it loses points

  • No legal entity name or physical address disclosed on site
  • Broader platform — not a GLP-1 specialist
  • $25 deposit required to book the provider consultation (unclear whether it is credited toward the program)
Queen RX

Graded #212 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard